VENN

Monos Closes Oversubscribed USD$30M Series B Investment Amid Travel Industry Comeback; Luggage Industry Veteran Joins Board

Retrieved on: 
Wednesday, September 21, 2022

The Series B funding round, which was oversubscribed with nearly USD$40 million in investor demand, comes after Monos achieved 4x growth in 2021, with a further 4x growth forecast in 2022.

Key Points: 
  • The Series B funding round, which was oversubscribed with nearly USD$40 million in investor demand, comes after Monos achieved 4x growth in 2021, with a further 4x growth forecast in 2022.
  • "Despite launching just before the travel industry was hit with unprecedented uncertainty, Monos thrived as aspiring travelers connected with our brand online," said Victor Tam, CEO and Co-founder.
  • It's what sets Monos apart and our growth over the past three years has positioned us well to capitalize on the explosion in travel now seen globally.
  • Monos is also welcoming former Samsonite, Louis Vuitton, and Pandora CEO Marcello Bottoli to its Board of Directors.

The Op | Usaopoly Releases VENN, A Clever Party Game Where Clues & Art Overlap

Retrieved on: 
Tuesday, August 9, 2022

CARLSBAD, Calif., Aug. 9, 2022 /PRNewswire/ -- Usaopoly (The Op), the board game and puzzle publisher behind best-selling party games Telestrations®, Blank Slate™, and Hues and Cues™ today unveiled the latest addition to its iconic line-up: VENN™, a clever party game where clues and art overlap. Utilizing a unique and creative game format, VENN challenges players to race to guess words based on the placement of surreal images in overlapping Venn diagram circles.

Key Points: 
  • CARLSBAD, Calif., Aug. 9, 2022 /PRNewswire/ -- Usaopoly (The Op) , the board game and puzzle publisher behind best-selling party games Telestrations, Blank Slate,and Hues and Cues today unveiled the latest addition to its iconic line-up: VENN , a clever party game where clues and art overlap.
  • This new signature game is easy to set up and encourages hands-on collaboration mixed with friendly competition and fun.
  • Whether it's a family game night or a corporate icebreaker, we're excited to introduce yet another signature game to our portfolio."
  • To learn more about The Op, visit www.TheOp.Games , and follow along on social ( @TheOpGames ) for more on the latest game announcements and launches.

Monos Travel Closes $10M Series A Investment, Poised to Establish Brand as Travel Industry Leader

Retrieved on: 
Tuesday, January 18, 2022

Monos offers premium travel luggage and accessories in timeless designs at accessible prices, unmatched within the industry, without sacrificing high-quality material and aesthetic.

Key Points: 
  • Monos offers premium travel luggage and accessories in timeless designs at accessible prices, unmatched within the industry, without sacrificing high-quality material and aesthetic.
  • Monos luggage features the highest quality parts and materials from around the world and is subjected to a battery of forty durability tests mimicking the rigors of everyday travel.
  • The durability of Monos pieces is core to the brands commitment to sustainability and conscientious traveling.
  • The Series A fundraise follows incredible growth for Monos in 2020 despite unprecedented challenges across the broader travel industry.

Canary RX Receives its Health Canada Sales License

Retrieved on: 
Wednesday, September 15, 2021

NORFOLK COUNTY, ON, Sept. 15, 2021 /PRNewswire/ - Target Group Inc. (OTCQB: CBDY)is pleased to announce that its wholly owned subsidiary, Canary Rx Inc. ("Canary" or the "Company") has received its Health Canada sales license.

Key Points: 
  • NORFOLK COUNTY, ON, Sept. 15, 2021 /PRNewswire/ - Target Group Inc. (OTCQB: CBDY)is pleased to announce that its wholly owned subsidiary, Canary Rx Inc. ("Canary" or the "Company") has received its Health Canada sales license.
  • Canary RX, through its joint venture partnership, Venn Cannabis, has been working meticulously to ensure production of ultra-premium, craft cannabis in its Simcoe, Ontario production facility.
  • Receiving the sales license at our Simcoe, Ontario facility is tremendously positive news for Canary RX and VENN, our joint-venture with Thrive Cannabis," saidTony Zarcone, CEO of Target Group & Canary RX Inc.
    Canary Rx Inc. ("Canary") isa Licensed Producerunder the Cannabis Act.
  • The Company owns and operates Canary RX Inc, a Health Canada licensed producer under The Cannabis Act (Bill C-45), and CannaKorp, makers of the pod-based Wisp Vapor technology.